$CNNN
ConneXionONE Corp.

2024 Q1 Form 10-K Financial Statement

#000168316824001257 Filed on March 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $114.9K $1.361M
YoY Change 234.82% 1371.76%
Operating Profit -$114.9K -$1.361M
YoY Change 234.82% 1371.76%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00
YoY Change
Pretax Income -$114.9K -$1.361M
YoY Change 234.82% 1371.76%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$114.9K -$1.361M
YoY Change 234.82% 1371.76%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 -$0.02
Diluted Earnings Per Share $0.00 -$0.02
COMMON SHARES
Basic Shares Outstanding 76.57M shares 71.85M shares 73.04M shares
Diluted Shares Outstanding 76.57M shares 73.04M shares

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $3.352K $725.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables $442.0K
Total Short-Term Assets $3.352K $442.7K
YoY Change -99.35% 14.98%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles $0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $572.0K $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $3.352K $442.7K
Total Long-Term Assets $572.0K $0.00
Total Assets $575.4K $442.7K
YoY Change 12.0% 14.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.388M $1.141M
YoY Change 53.36% 53.69%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities $1.003M $1.003M
YoY Change 0.0% 0.0%
Total Long-Term Liabilities $1.003M $1.003M
YoY Change 0.0% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.388M $1.141M
Total Long-Term Liabilities $1.003M $1.003M
Total Liabilities $2.391M $2.143M
YoY Change 25.32% 22.84%
SHAREHOLDERS EQUITY
Retained Earnings -$75.41M -$75.29M
YoY Change 1.95% 1.84%
Common Stock $76.57K $76.57K
YoY Change 6.57% -99.89%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.816M -$1.701M
YoY Change
Total Liabilities & Shareholders Equity $575.4K $442.7K
YoY Change 12.0% 14.98%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$114.9K -$1.361M
YoY Change 234.82% 1371.76%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$116.5K -$90.69K
YoY Change 239.33% 560.01%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$130.0K -$132.0K
YoY Change -1.52% -65.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $249.1K $218.4K
YoY Change 52.83% -45.24%
NET CHANGE
Cash From Operating Activities -$116.5K -$90.69K
Cash From Investing Activities -$130.0K -$132.0K
Cash From Financing Activities $249.1K $218.4K
Net Change In Cash $2.627K -$4.307K
YoY Change -178.96% -185.59%
FREE CASH FLOW
Cash From Operating Activities -$116.5K -$90.69K
Capital Expenditures $0.00
Free Cash Flow -$116.5K
YoY Change 239.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001182731
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
usd
CY2022 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
0 usd
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
000-50075
CY2023 dei Entity Registrant Name
EntityRegistrantName
CONNEXIONONE CORP.
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NC
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
30-1252905
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
530 Lytton Ave 2nd Floor #2061
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Palo Alto
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94301
CY2023 dei City Area Code
CityAreaCode
408
CY2023 dei Local Phone Number
LocalPhoneNumber
533-8155
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2023 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
19924373 usd
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
76571644 shares
CY2023 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023 dei Auditor Firm
AuditorFirmId
5041
CY2023 dei Auditor Name
AuditorName
BF Borgers CPA PC
CY2023 dei Auditor Location
AuditorLocation
Lakewood, CO
CY2023Q4 us-gaap Cash
Cash
725 usd
CY2022Q4 us-gaap Cash
Cash
5032 usd
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
442000 usd
CY2022Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
380000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
442725 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
385032 usd
CY2023Q4 us-gaap Assets
Assets
442725 usd
CY2022Q4 us-gaap Assets
Assets
385032 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
42499 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
88250 usd
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
225888 usd
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
0 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
872446 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
654068 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1140833 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
742318 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1002639 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1002639 usd
CY2023Q4 us-gaap Liabilities
Liabilities
2143472 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1744957 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
76571644 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
76571644 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71850644 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71850644 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
76572 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
71851 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
73515021 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
72499335 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-75292340 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-73931111 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1700747 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1359925 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
442725 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
385032 usd
CY2023 us-gaap Revenues
Revenues
0 usd
CY2022 us-gaap Revenues
Revenues
0 usd
CY2023 us-gaap Professional Fees
ProfessionalFees
57450 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
77390 usd
CY2023 CNNN Management Fees
ManagementFees
20000 usd
CY2022 CNNN Management Fees
ManagementFees
0 usd
CY2023 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
1020407 usd
CY2022 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
0 usd
CY2023 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
263372 usd
CY2022 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
15100 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
1361229 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
92490 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-1361229 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-92490 usd
CY2023 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
0 usd
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
0 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1361229 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-92490 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-1361229 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-92490 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.019
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.019
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.001
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.001
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73044017 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
73044017 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73106918 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
73106918 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1267435 usd
CY2022 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
0 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-92490 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1359925 usd
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1020407 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-1361229 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-1700747 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-1361229 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-92490 usd
CY2023 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
1020407 usd
CY2022 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable And Other Operating Assets
IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
-70000 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable And Other Operating Assets
IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
-0 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-45751 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
78750 usd
CY2023 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
225888 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-90685 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13740 usd
CY2023 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
132000 usd
CY2022 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
379900 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-132000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-379900 usd
CY2023 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
218378 usd
CY2022 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
398672 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
218378 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
398672 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-4307 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
5032 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5032 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
725 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5032 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
0 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84D_eus-gaap--UseOfEstimates_zr9h1emamARi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration: underline">Use of estimates</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s significant estimates include income taxes provision and valuation allowance of deferred tax assets; the fair value of financial instruments; the carrying value and recoverability of long-lived assets, including the values assigned to an estimated useful lives of computer equipment; and the assumption that the Company will continue as a going concern. Those significant accounting estimates or assumptions bear the risk of change due to the fact that there are uncertainties attached to those estimates or assumptions, and certain estimates or assumptions are difficult to measure or value. Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Management regularly reviews its estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such reviews, and if deemed appropriate, those estimates are adjusted accordingly. Actual results could differ from those estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-75292340 usd
CY2023Q4 CNNN Liabilities Carryover From Prior Abandoned Operations
LiabilitiesCarryoverFromPriorAbandonedOperations
665735 usd
CY2022Q4 CNNN Liabilities Carryover From Prior Abandoned Operations
LiabilitiesCarryoverFromPriorAbandonedOperations
665735 usd
CY2023Q4 CNNN Accrual Carryover From Prior Abandoned Operations
AccrualCarryoverFromPriorAbandonedOperations
336904 usd
CY2022Q4 CNNN Accrual Carryover From Prior Abandoned Operations
AccrualCarryoverFromPriorAbandonedOperations
336904 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1002639 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1002639 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1002639 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1002639 usd
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
76571644 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
76571644 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71850644 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71850644 shares
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
1200000 shares
CY2023Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
reverse stock split of a one-for-one thousand (1:1,000)
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
75135153 usd

Files In Submission

Name View Source Status
0001683168-24-001257-index-headers.html Edgar Link pending
0001683168-24-001257-index.html Edgar Link pending
0001683168-24-001257.txt Edgar Link pending
0001683168-24-001257-xbrl.zip Edgar Link pending
cnnn-20231231.xsd Edgar Link pending
cnnn_10k-123123.htm Edgar Link pending
cnnn_ex3101.htm Edgar Link pending
cnnn_ex3102.htm Edgar Link pending
cnnn_ex3201.htm Edgar Link pending
cnnn_ex3202.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
cnnn_10k-123123_htm.xml Edgar Link completed
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cnnn-20231231_cal.xml Edgar Link unprocessable
cnnn-20231231_def.xml Edgar Link unprocessable
cnnn-20231231_lab.xml Edgar Link unprocessable
cnnn-20231231_pre.xml Edgar Link unprocessable